44 phd-in-architecture-interior-design-built-environment Postdoctoral positions in Canada
Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
Applications to the Runway Startup Postdoc Program open on October 15 and close on February 15. Recently completed your PhD and want to harness your deep tech expertise to start a company? Want to
-
: Advancing policy and programmatic research on the science of pandemic prevention and health emergencies (not lab-based) Supporting the design and evaluation of real-time data systems and pandemic prevention
-
. Strong publication record demonstrating independent research and analytical innovation. Excellent communication and teamwork skills in a multi-institutional and interdisciplinary environment. Other
-
: - Development of pro-drug of existing BRaf inhibitors - Synthesis and biological evaluation of BRaf inhibitors - Application of software for drug design - Learn to lead and manage projects - Oversee graduate
-
the materials science and manufacturing related to steel. The postdoc should have experience in the physics of materials and advanced computing. Qualifications: PhD in related field Annual Salary: $63,500.00
-
of junior students Writing papers Composing and writing research proposals Speaking at international conferences Qualifications: PhD in Chemistry Before applying, please note that to work at McGill University
-
: - Conduct advanced computational research. - Write and publish scientific articles. - Present work at conferences. - Participate in group meetings. - Contribute to publications. Qualifications: PhD in
-
this work will inform strategies to reduce discrimination and promote equity in HIV care and prevention. Key Responsibilities Design and implement systematic review protocols. Manage and harmonize multi
-
. Collaborate with internationally recognized leaders in computational neuro-oncology. Thrive in The Neuro’s open-science environment, fostering data sharing and interdisciplinary innovation. Before applying
-
designed to bridge the knowledge and validation gap in treating rare subtypes of hard-to-treat cancers on an individual basis, and deliver innovative, personalised treatments that will improve patient